462 results on '"Punt, C."'
Search Results
2. FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty
3. First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study
4. The association between preoperative fatigue and instrumental activities in daily living with complications and length of hospital stay in patients undergoing colorectal surgery
5. Modulation of Hypoxia in Murine Liver Metastases of Colon Carcinoma by Nicotinamide and Carbogen
6. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer
7. Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
8. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
9. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
10. Comparison of symptom clusters associated with fatigue in older and younger survivors of colorectal cancer
11. Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study
12. How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials
13. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)
14. Mitochondrial microsatellite instability in patients with metastatic colorectal cancer
15. A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion
16. The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
17. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
18. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy
19. RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up
20. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study)
21. Real-world resource use and costs of adjuvant treatment for stage III colon cancer
22. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial†
23. Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach
24. Assessment of Blood Hemodynamics by USPIO-Induced R 1 Changes in MRI of Murine Colon Carcinoma
25. Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
26. Dendritic cell vaccination and immune monitoring
27. Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation
28. Reproducibility and biological basis of in vivo T2* magnetic resonance imaging of liver metastasis of colorectal cancer
29. In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients
30. Targeted therapy in advanced colorectal cancer, an update
31. Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas
32. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
33. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
34. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
35. Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer
36. The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab
37. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
38. A prospective monitoring of fatal serious adverse events (SAEs) in a Dutch Colorectal Cancer Group (DCCG) phase III trial (CAIRO) in patients with advanced colorectal cancer
39. Tracing best PEEP by applying PEEP as a RAMP
40. A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
41. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
42. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer
43. DENDRITIC CELL VACCINATION AND IMMUNE MONITORING: 1CT-03
44. Dendritic cell vaccination and immune monitoring
45. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity
46. Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer
47. EORTC 18991: long term adjuvant pegylated interferon-α2b (PEG-IFN) vs observation in resected stage III melanoma:final results of a randomized phase 3 trial: EV9
48. DNA copy number profiles of primary colorectal cancers as predictors of response to therapy
49. FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma
50. Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.